1-5 of 5
Harald Stein, MD PhD Dr. h.c.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

BCR-Assosiated Kinase Inhibition in Relapsed/Refractory Chronic Lymphocytic Leukemia. Real World Experiences of a German Regional Clinical Register

Dietrich Kaempfe, MD, Roshanak Bob, MD, Joerg Brenn, Thomas Haverkamp, MD, Agnes Knopp, MD, Harald Stein, MD PhD Dr. h.c., Sebastian Böttcher, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 11.
https://doi.org/10.1182/blood-2020-134686
Published: 2020
Journal Articles

Clinicogenetic Risk Models in Patients Randomized to Receive Consolidative Autologous Stem-Cell Transplantation after Frontline R-CHOP for Advanced Follicular Lymphoma: An Analysis from the GLSG2000 Trial

Stefan Alig, MD, Alessandro Pastore, Vindi Jurinovic, Sarah Häbe, Deepak Bararia, PhD, Verena Passerini, PhD, William Keay, Johannes Hellmuth, Andreas Rosenwald, Wolfram Klapper, MD, Harald Stein, MD PhD Dr. h.c., Alfred Feller, German Ott, MD, Annette M. Staiger, PhD, Heike Horn, Martin-Leo Hansmann, Christiane Pott, Roswitha Forstpointner, Wolf-Karsten Hofmann, Norbert Schmitz, MD, Georg Hess, Michael Unterhalt, Martin H. Dreyling, MD PhD, Anna-Katharina Zoellner, Christian Schmidt, MD, Eva Hoster, Wolfgang Hiddemann, Oliver Weigert, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4096.
https://doi.org/10.1182/blood-2018-99-118000
Published: 2018
Journal Articles

A New Stromal Signature Applicable to Formalin-Fixed Paraffin-Embedded Tissues Identifies Patients at Risk in Prospective Clinical Trials of the German High-Grade Non-Hodgkin Lymphoma Study Group

Annette M. Staiger, PhD, Michael Altenbuchinger, PhD, Marita Ziepert, PhD, Christian Kohler, PhD, Heike Horn, Michael Huttner, Katrin Huettl, MD, Wolfram Klapper, MD, Monika Szczepanowski, PhD, Julia Richter, PhD, Andreas Rosenwald, Harald Stein, MD PhD Dr. h.c., Alfred Feller, Peter Moeller, MD, Martin-Leo Hansmann, Markus Loeffler, MD, Viola Poeschel, MD, Gerhard Held, MD, Lorenz Truemper, MD, German Ott, MD, Rainer Spang, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 343.
https://doi.org/10.1182/blood-2018-99-112450
Published: 2018
Journal Articles

Alisertib (MLN8237), an Oral Selective Inhibitor of Aurora Kinase a, Has Clinical Activity and Restores GATA1 Expression in Patients with Myelofibrosis

Naseema Gangat, MBBS, Brady Lee Stein, MD, Christian Marinaccio, Ronan Swords, MD PhD, Justin M. Watts, MD, Sandeep Gurbuxani, Olga Frankfurt, MD, Jessica K. Altman, MD, Jeremy Q. Wen, MD PhD, Noushin Farnoud, PhD, Christopher Famulare, MS, Akshar Patel, BA, Roberto Tapia, BS, Amy Handlogten, Yvonne Trang Dinh, BS, Kristen Englund, Shradha Patel, Juan Carlos Nobrega, Dalissa Tejera, MSN, Amber Thomassen, Harald Stein, MD PhD Dr. h.c., Juehua Gao, MD PhD, Peng Ji, MDPhD, Raajit K. Rampal, MD PhD, Francis J. Giles, MD FRCPI, FRCPath, Ayalew Tefferi, MD, John D. Crispino, PhD MBA
Journal: Blood
Blood (2018) 132 (Supplement 1): 688.
https://doi.org/10.1182/blood-2018-99-110381
Published: 2018
Journal Articles

Real Life Dates of Chronic Lymphocytic Leukemia (CLL) in Germany. Interim Analysis of 234 Consecutively New Diagnosed Patients in a German Epidemiological-Clinical Register

Dietrich Kämpfe, MD, Harald Stein, MD PhD Dr. h.c., Roshanak Bob, MD, Sebastian Böttcher, Joerg Brenn, Agnes Knopp, MD, Thomas Haverkamp, MD, Christoph Schulte, MD, Detlef Haase, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2264.
https://doi.org/10.1182/blood-2018-99-110618
Published: 2018